Abstract
In this paper, using a hybrid small-animal Micro SPECT/CT imaging system, we report that a new (125)I-Cilengitide-like RGD-cyclopentapeptide, containing d-morpholine-3-carboxylic acid, interacts in vivo with α(v)β(3) integrin expressed by melanoma cells. Images clearly show that the (125)I-compound has the capacity to monitor the growth of a melanoma xenograft. Indeed, retention of the labeled ligand in the tumor mass has a good tumor/background ratio, and a significant reduction of its uptake was observed after injection of unlabeled ligand. These results suggest that the use of (125)I-labeled morpholine-based RGD-cyclopentapeptides targeting α(v)β(3) positive tumors may play a role in future therapeutic strategies.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Cell Adhesion
-
Cell Movement
-
Human Umbilical Vein Endothelial Cells / cytology
-
Human Umbilical Vein Endothelial Cells / drug effects
-
Humans
-
Integrin alphaVbeta3 / metabolism*
-
Iodine Radioisotopes
-
Ligands
-
Melanoma / diagnostic imaging
-
Models, Molecular
-
Molecular Probes / chemical synthesis*
-
Molecular Probes / chemistry
-
Molecular Probes / pharmacokinetics
-
Morpholines / chemical synthesis*
-
Morpholines / chemistry
-
Morpholines / pharmacokinetics
-
Multimodal Imaging
-
Neoplasm Transplantation
-
Neovascularization, Pathologic / diagnostic imaging*
-
Oligopeptides / chemical synthesis*
-
Oligopeptides / pharmacokinetics
-
Oligopeptides / pharmacology
-
Peptides, Cyclic / chemical synthesis*
-
Peptides, Cyclic / chemistry
-
Peptides, Cyclic / pharmacokinetics
-
Peptides, Cyclic / pharmacology
-
Positron-Emission Tomography
-
Radiopharmaceuticals / chemical synthesis*
-
Radiopharmaceuticals / chemistry
-
Radiopharmaceuticals / pharmacokinetics
-
Stereoisomerism
-
Structure-Activity Relationship
-
Tissue Distribution
-
Tomography, X-Ray Computed
-
Transplantation, Heterologous
Substances
-
Integrin alphaVbeta3
-
Iodine Radioisotopes
-
Ligands
-
Molecular Probes
-
Morpholines
-
Oligopeptides
-
Peptides, Cyclic
-
Radiopharmaceuticals
-
arginyl-glycyl-aspartic acid